Search
Menu
Excelitas Technologies Corp. - X-Cite Vitae LB 11/24

LENSAR Spinoff Completed

Facebook X LinkedIn Email
New company to trade on Nasdaq.

PDL BioPharma Inc. announced the completion of the previously announced spinoff of its femtosecond laser system business LENSAR. Beginning Oct. 2, LENSAR shares began “regular way” trading on the Nasdaq composite exchange. LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of preexisting or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist surgeons in obtaining...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: October 2020
    BusinessLasersfemtosecondfemtosecond lasersfemtosecond lasers for cataract surgerycataractcataract surgerycataractslaser surgery for cataractsmedicalmedical devicestockstock marketNasdaqRapidScan

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.